A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial

Affiliations

¹ DINOGMI, University of Genoa, Genova, Italy.
² Sant Pau Hospital, Universitat Aut'onoma de Barcelona, CIBERNED, Barcelona, Spain.
³ Department of Neurology, AZ St-Jan Brugge-Oostende AV, Campus Brugge, Brugge & Ghent University Hospital, Ghent, Belgium.
⁴ Biocruces Research Institute, Barakaldo, Spain.
⁵ Department of Neurology, Cantonal Hospital St.Gallen, Switzerland.
⁶ Fairfield General Hospital, Bury, Greater Manchester, UK.
⁷ Parkinson Center, University Policlinico Tor Vergata, Roma, Italy.
⁸ Department of Neurology, University of Muenster, Muenster, Germany.
⁹ Parkinson-Klinik Ortenau, University of Freiburg, Wolfach, Germany.

Published Erratum

Giovanni Abbruzzese et al. J Parkinsons Dis. 2022.

. 2022;12(1):473.

doi: 10.3233/JPD-219007.

¹ DINOGMI, University of Genoa, Genova, Italy.
² Sant Pau Hospital, Universitat Aut'onoma de Barcelona, CIBERNED, Barcelona, Spain.
³ Department of Neurology, AZ St-Jan Brugge-Oostende AV, Campus Brugge, Brugge & Ghent University Hospital, Ghent, Belgium.
⁴ Biocruces Research Institute, Barakaldo, Spain.
⁵ Department of Neurology, Cantonal Hospital St.Gallen, Switzerland.
⁶ Fairfield General Hospital, Bury, Greater Manchester, UK.
⁷ Parkinson Center, University Policlinico Tor Vergata, Roma, Italy.
⁸ Department of Neurology, University of Muenster, Muenster, Germany.
⁹ Parkinson-Klinik Ortenau, University of Freiburg, Wolfach, Germany.

No abstract available

Erratum for

A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial.
Abbruzzese G, Kulisevsky J, Bergmans B, Gomez-Esteban JC, Kägi G, Raw J, Stefani A, Warnecke T, Jost WH; SYNAPSES Study Investigators Group. Abbruzzese G, et al. J Parkinsons Dis. 2021;11(1):187-198. doi: 10.3233/JPD-202224. J Parkinsons Dis. 2021. PMID: 33104040 Free PMC article. Clinical Trial.